SCD-HeFT Results Justify Expanded ICD Coverage – Medtronic’s Stanton
A CMS policy restricting ICD national coverage to a subgroup of the SCD-HeFT trial would undermine future clinical trial investment, according to Medtronic's Marshall Stanton, MD
A CMS policy restricting ICD national coverage to a subgroup of the SCD-HeFT trial would undermine future clinical trial investment, according to Medtronic's Marshall Stanton, MD